Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development

被引：35

作者：

Harrington, KJ

Lewanski, CR

Stewart, JSW

机构：

[1] Mayo Clin, Program Mol Med, Rochester, MN 55902 USA

[2] Hammersmith Hosp, Imperial Canc Res Fund, Imperial Coll Sci Technol & Med, Oncol Unit, London, England

[3] Charing Cross Hosp, Dept Radiotherapy, London, England

来源：

CLINICAL ONCOLOGY | 2000年 / 12卷 / 01期

关键词：

D O I：

10.1053/clon.2000.9105

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：16 / 24

页数：9

共 81 条

[41]

LANGLEY RE, 1998, P AN M AM SOC CLIN, V17, pA246

[42]

Lasic DD, 1999, CURR OPIN MOL THER, V1, P177

[43]

LAUFMAN LR, 1998, P AN M AM SOC CLIN, V17, pA246

[44] TREATMENT METHODS FOR EXTRAVASATIONS OF CHEMOTHERAPEUTIC-AGENTS - A COMPARATIVE-STUDY [J].

LOTH, TS ;

EVERSMANN, WW .

JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1986, 11A (03) :388-396

[45]

LYASS O, 1998, P ASCO, V17, pA156

[46] LACK OF VESICANT INJURY FOLLOWING EXTRAVASATION OF LIPOSOMAL DOXORUBICIN [J].

MADHAVAN, S ;

NORTHFELT, DW .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (20) :1556-1557

[47] THERAPY OF HUMAN OVARIAN-CANCER XENOGRAFTS WITH INTRAPERITONEAL LIPOSOME ENCAPSULATED MURAMYL-TRIPEPTIDE PHOSPHOETHANOLAMINE (MTP-PE) AND RECOMBINANT GM-CSF [J].

MALIK, STA ;

MARTIN, D ;

HART, I ;

BALKWILL, F .

BRITISH JOURNAL OF CANCER, 1991, 63 (03) :399-403

[48]

MALIK UR, 1998, P AN M AM SOC CLIN, V17, pA175

[49]

Money-Kyrle J F, 1993, Clin Oncol (R Coll Radiol), V5, P367, DOI 10.1016/S0936-6555(05)80088-3

[50] Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation [J].

Muggia, FM ;

Hainsworth, JD ;

Jeffers, S ;

Miller, P ;

Groshen, S ;

Tan, M ;

Roman, L ;

Uziely, B ;

Muderspach, L ;

Garcia, A ;

Burnett, A ;

Greco, FA ;

Morrow, CP ;

Paradiso, LJ ;

Liang, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :987-993

← 1 2 3 4 5 6 7 8 9 →